Alternative pathway to reduced artemisinin susceptibility in

Ryan C. Henrici, MD, PhD, Center for Global Health

Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin: a systematic review - ScienceDirect

Full article: Toward a better understanding of metabolic and pharmacokinetic characteristics of low-solubility, low-permeability natural medicines

Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal

A novel Modulator of Ring Stage Translation (MRST) gene alters artemisinin sensitivity in Plasmodium falciparum - ScienceDirect

PDF) Single cell transcriptional changes across the blood stages of artemisinin resistant K13C580Y mutant Plasmodium falciparum upon dihydroartemisinin exposure

PDF) Prevalence of potential mediators of artemisinin resistance in African isolates of Plasmodium falciparum

PDF) Randomised controlled trial of two sequential artemisinin-based combination therapy regimens to treat uncomplicated falciparum malaria in African children: A protocol to investigate safety, efficacy and adherence

PDF) Prevalence of potential mediators of artemisinin resistance in African isolates of Plasmodium falciparum

PDF) The Plasmodium falciparum Artemisinin Susceptibility-Associated AP-2 Adaptin μ Subunit is Clathrin Independent and Essential for Schizont Maturation

PDF) Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial

Colin J. Sutherland's research works London School of Hygiene and Tropical Medicine, London (LSHTM) and other places

A novel Modulator of Ring Stage Translation (MRST) gene alters artemisinin sensitivity in Plasmodium falciparum - ScienceDirect